AI Article Synopsis

  • Amino acid substitutions at residue I223 in the neuraminidase protein of pH1N1 variants affect their resistance to NA inhibitors, with specific mutations like H275Y significantly increasing drug resistance.
  • Reverse genetics and mutagenesis were employed to create various NA mutants, revealing distinct susceptibility patterns to oseltamivir, zanamivir, and peramivir, with some mutants showing dramatically higher IC(50)s compared to the wild-type virus.
  • Viral titers and transmission in ferrets were similar for both the wild-type and certain mutant strains, indicating that these amino acid changes can lead to drug resistance without impacting the virus's overall fitness, highlighting the need for ongoing surveillance of these mutations

Article Abstract

Amino acid substitutions at residue I223 of the neuraminidase (NA) protein have been identified in 2009 pandemic influenza (pH1N1) variants with altered susceptibilities to NA inhibitors (NAIs). We used reverse genetics and site-directed mutagenesis to generate the recombinant A/Québec/144147/09 pH1N1 wild-type virus (WT) and five (I223R, I223V, H275Y, I223V-H275Y, and I223R-H275Y) NA mutants. A fluorimetry-based assay was used to determine 50% inhibitory concentrations (IC(50)s) of oseltamivir, zanamivir, and peramivir. Replicative capacity was analyzed by viral yield assays in ST6GalI-MDCK cells. Infectivity and transmission of the WT, H275Y, and I223V-H275Y recombinant viruses were evaluated in ferrets. As expected, the H275Y mutation conferred resistance to oseltamivir (982-fold) and peramivir (661-fold) compared to the drug-susceptible recombinant WT. The single I223R mutant was associated with reduced susceptibility to oseltamivir (53-fold), zanamivir (7-fold) and peramivir (10-fold), whereas the I223V virus had reduced susceptibility to oseltamivir (6-fold) only. Interestingly, enhanced levels of resistance to oseltamivir and peramivir and reduced susceptibility to zanamivir (1,647-, 17,347-, and 16-fold increases in IC(50)s, respectively) were observed for the I223R-H275Y recombinant, while the I223V-H275Y mutant exhibited 1,733-, 2,707-, and 2-fold increases in respective IC(50)s. The I223R and I223V changes were associated with equivalent or higher viral titers in vitro compared to the recombinant WT. Infectivity and transmissibility in ferrets were comparable between the recombinant WT and the H275Y or I223V-H275Y recombinants. In conclusion, amino acid changes at residue I223 may alter the NAI susceptibilities of pH1N1 variants without compromising fitness. Consequently, I223R and I223V mutations, alone or with H275Y, need to be thoroughly monitored.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3294894PMC
http://dx.doi.org/10.1128/AAC.05994-11DOI Listing

Publication Analysis

Top Keywords

residue i223
12
i223r i223v
12
h275y i223v-h275y
12
reduced susceptibility
12
i223 neuraminidase
8
neuraminidase protein
8
2009 pandemic
8
pandemic influenza
8
amino acid
8
ph1n1 variants
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!